StemCells Inc Share Price Nasdaq
Stocks
US85857R2040
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| Market Cap | 128M 112M 103M 96.07M 182M 12.21B 185M 1.24B 481M 6B 482M 471M 20.69B | P/E 2026 * |
-6.37x | P/E 2027 * | -5.97x |
|---|---|---|---|---|---|
| Enterprise Value | 128M 112M 103M 96.07M 182M 12.21B 185M 1.24B 481M 6B 482M 471M 20.69B | EV / Sales 2026 * |
37.2x | EV / Sales 2027 * | 12.1x |
| Free-Float |
100% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: StemCells Inc
| Manager | Title | Age | Since |
|---|---|---|---|
Harel Gadot
CEO | Chief Executive Officer | 54 | 01/08/1988 |
Rachel Vaknin
DFI | Director of Finance/CFO | 47 | 31/03/2022 |
Michal Ahuvia
COO | Chief Operating Officer | - | 20/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Harel Gadot
CHM | Chairman | 54 | 31/12/2012 |
Scott Burell
BRD | Director/Board Member | 61 | 27/11/2016 |
Martin Madden
BRD | Director/Board Member | 65 | 05/02/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.70% | +7.41% | +2.50% | +8.22% | 49.92B | |
| +0.92% | +3.93% | +399.71% | +605.33% | 40.23B | |
| +1.89% | +8.32% | +26.06% | -6.35% | 34.55B | |
| +2.38% | +6.35% | +21.25% | +64.58% | 33.09B | |
| +3.96% | +10.67% | +8.30% | +40.44% | 27.51B | |
| +2.51% | +5.27% | - | - | 17.05B | |
| +2.58% | +5.79% | +73.44% | +133.27% | 15.92B | |
| +0.32% | +0.58% | +14.00% | +19.59% | 13.86B | |
| +3.30% | +0.76% | +90.23% | +99.12% | 13.52B | |
| Average | +2.17% | +5.82% | +79.44% | +120.52% | 27.3B | |
| Weighted average by Cap. | +2.07% | +6.53% | +90.20% | +137.91% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.45M 3.02M 2.77M 2.58M 4.9M 328M 4.97M 33.27M 12.94M 161M 12.95M 12.67M 556M | 10.6M 9.27M 8.52M 7.94M 15.06M 1.01B 15.28M 102M 39.74M 496M 39.79M 38.93M 1.71B |
| Net income | -20.45M -17.88M -16.43M -15.31M -29.05M -1.95B -29.49M -197M -76.68M -957M -76.76M -75.11M -3.3B | -21.45M -18.75M -17.23M -16.06M -30.47M -2.04B -30.93M -207M -80.42M -1B -80.51M -78.79M -3.46B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
